The present invention provides halogenated calixpyrrole, calixpyridinopyrrole, and calixpyridine macrocycles having 4-12 pyrrolic rings with greater stability, enhanced anion and neutral molecule binding affinity, and different binding selectivites as compared to their non-halogenated congeners as judged from 1H NMR, 19F NMR and fluorescence emission spectroscopic analyses.

 
Web www.patentalert.com

< Antibodies to a YYX epitope of a mammalian prion protein

< Canine herpes virus alpha transinducing factor nucleic acid molecules

> Method and system for myocardial infarction repair

> Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase

~ 00259